Trans-resveratrol loaded chitosan nanoparticles modified with biotin and avidin to target hepatic carcinoma

International Journal of Pharmaceutics

Volumn 452, Issue 1-2, 2013, Pages 355-362

  Bu, Le ^a,b   Gan, Liang Chun ^c   Guo, Xiao Qiang ^a   Chen, Feng Zheng ^a   Song, Qin ^a   Zhao, Qi ^a   Gou, Xiao Jun ^a   Hou, Shi Xiang ^d   Yao, Qian ^a  

^a CHENGDU UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Sichuan Food and Drug Safety Monitoring and Evaluation Certification Center   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Avidin; Biotin; Chitosan nanoparticles; Hepatic carcinoma; Pharmacokinetics; Target

Indexed keywords

AVIDIN; BIOTIN; CHITOSAN; NANOCARRIER; RESVERATROL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN HEPG2; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG RELEASE; DRUG SYNTHESIS; ENCAPSULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; KUNMING MOUSE; LIVER CELL CARCINOMA; MAXIMUM PLASMA CONCENTRATION; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84884211101     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.05.007     Document Type: Article

References (48)

1. Balthasar, S., Michaelis, K., Dinauer, N., von Briesen, H., Kreuter, J., Langer, K., 2005. Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes. Biomaterials 26, 2723-2732. (Pubitemid 39600725)
2. Celej, M.S., Montich, G.G., Fidelio, G.D., 2004. Conformational flexibility of avidin: the influence of biotin binding. Biochem. Biophys. Res. Commun. 325, 922-927. (Pubitemid 39487960)
3. Chen, J., Chen, S., Zhao, X., Kuznetsova, L.V., Wong, S.S., Ojima, I., 2009. Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery. J. Am. Chem. Soc. 130, 16778-16785.
4. Chen, Z., Yu, D., Liu, C., Yang, X., Zhang, N., Ma, C., Song, J., Lu, Z., 2011. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent. J. Drug Target. 19, 657-665.
5. Chinol, M., De Cobelli, O., Trifirò, G., Scardino, E., Bartolomei, M., Verweij, F., Papi, S., Matei, D.V., Paganelli, G., 2003. Localization of avidin in superficial bladder cancer: a potentially new approach for radionuclide therapy. Eur. Urol. 44, 556-559. (Pubitemid 37328631)
6. 99mTc-DTPA-bis-biotin in rat AS-30D-hepatoma cells. Nucl. Med. Biol. 30, 135-140.
7. Gao, F., Li, L., Liu, T., Hao, N., Liu, H., Tan, L., Li, H., Huang, X., Peng, B., Yan, C., Yang, L., Wu, X., Chen, D., Tang, F., 2012. Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects. Nanoscale 4, 3365-3372.
8. Hama, Y., Urano, Y., Koyama, Y., Choyke, P.L., Kobayashi, H., 2006. Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin. Biochem. Biophys. Res. Commun. 348, 807-813. (Pubitemid 44233491)
9. Hama, Y., Urano, Y., Koyama, Y., Kamiya, M., Bernardo, M., Paik, R.S., Shin, I.S., Paik, C.H., Choyke, P.L., Kobayashi, H., 2007. A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate. Cancer Res. 67, 2791-2799. (Pubitemid 46548968)
10. Heo, D.N., Yang, D.H., Moon, H.J., Lee, J.B., Bae, M.S., Lee, S.C., Lee, W.J., Sun, I.C., Kwon, I.K., 2012. Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials 33, 856-866.
11. Huang, W., Wang, W., Wang, P., Zhang, C.N., Tian, Q., Zhang, Y., Wang, X.H., Cha, R.T., Wang, C.H., Yuan, Z., 2011. Glycyrrhetinic acid-functionalized degradable micelles as liver-targeted drug carrier. J. Mater. Sci. Mater. Med. 22, 853-863.
12. Ji, Z., Lin, G., Lu, Q., Meng, L., Shen, X., Dong, L., Fu, C., Zhang, X., 2012. Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system. J. Colloid Interface Sci. 365, 143-149.
13. Jiang, X., Ren, Y., Williford, J.M., Li, Z., Mao, H.Q., 2013. Liver-targeted gene delivery through retrograde intrabiliary infusion. Methods Mol. Biol. 948, 275-284.
14. Kim, J.H., Li, Y., Kim, M.S., Kang, S.W., Jeong, J.H., Lee, D.S., 2012. Synthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers. Int. J. Pharm. 427, 435-442.
15. Lesch, H.P., Kaikkonen, M.U., Pikkarainen, J.T., Ylä-Herttuala, S., 2010. Avidin-biotin technology in targeted therapy. Expert Opin. Drug Deliv. 7, 551-564.
16. Li, M., Lam, J.W.Y., Mahtab, F., Chen, S., Zhang, W., Hong, Y., Xiong, J., Zheng, Q., Tang, B.Z., 2013. Biotin-decorated fluorescent silica nanoparticles with aggregation-induced emission characteristics: fabrication, cytotoxicity and biological applications. J. Mater. Chem. B 1, 676-684.
17. Li, X., Huang, Y., Chen, X., Zhou, Y., Zhang, Y., Li, P., Liu, Y., Sun, Y., Zhao, J., Wang, F., 2009. Self-assembly and characterization of Pluronic P105 micelles for liver-targeted delivery of silybin. J. Drug Target. 17, 739-750.
18. Lindegren, S., Frost, S.H., 2011. Pretargeted radioimmunotherapy with α-particle emitting radionuclides. Curr. Radiopharm. 4, 248-260.
19. Lotan, R., Raz, A., 1988. Lectins in cancer cells. Ann. N. Y. Acad. Sci. 551, 385-396.
20. Mårtensson, L., Nilsson, R., Ohlsson, T., Sjögren, H.O., Strand, S.E., Tennvall, J., 2007. Improved tumor targeting and decreased normal tissue accumulation through extracorporeal affinity adsorption in a two-step pretargeting strategy. Clin. Cancer Res. 13, 5572s-5576s. (Pubitemid 47510389)
21. 123I-labeled avidin: evaluation of a two-step strategy. Invest. New Drugs 30, 2132-2140.
22. Monsigny, M., Roche, A.C., Midoux, P., 1988. Endogenous lectins and drug targeting. Ann. N. Y. Acad. Sci. 551, 399-414. (Pubitemid 19172157)
23. Ogawa, M., Kosaka, N., Longmire, M.R., Urano, Y., Choyke, P.L., Kobayashi, H., 2009. Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases. Mol. Pharmacol. 6, 386-395.
24. Patel, M., Vadlapatla, R.K., Shah, S., Mitra, A.K., 2012. Molecular expression and functional activity of sodium dependent multivitamin transporter in human prostate cancer cells. Int. J. Pharm. 436, 324-331.
25. Rosebrough, S.F., 1993. Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin and biotin. Nucl. Med. Biol. 20, 663-668. (Pubitemid 23175371)
26. Rosebrough, S.F., Hartley, D.F., 1996. Biochemical modification of streptavidin and avidin: in vitro and in vivo analysis. J. Nucl. Med. 37, 1380-1384. (Pubitemid 26330678)
27. Russell-Jones, G., McTavish, K., McEwan, J., Rice, J., Nowotnik, D., 2004. Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours. J. Inorg. Biochem. 98, 1625-1633. (Pubitemid 39349188)
28. Sakahara, H., Saga, T., 1999. Avidin-biotin system for delivery of diagnostic agents. Adv. Drug Deliv. Rev. 37, 89-101. (Pubitemid 29164502)
29. Schechter, B., Silberman, V.R., Arnon, R., Wilchek, M., 1990. Tissue distribution of avidin and streptavidin injected to mice. Eur. J. Biochem. 189, 327-331.
30. Shen, Z., Wei, W., Tanaka, H., Kohama, K., Ma, G., Dobashi, T., Maki, Y., Wang, H., Bi, J., Dai, S., 2011. A galactosamine-mediated drug delivery carrier for targeted liver cancer therapy. Pharmacol. Res. 64, 410-419.
31. Singh, A., Dilnawaz, F., Sahoo, S.K., 2011. Long circulating lectin conjugated paclitaxel loaded magnetic nanoparticles: a new theranostic avenue for leukemia therapy. PLoS One 6, e26803.
32. Su, J., Chen, F., Cryns, V.L., Messersmith, P.B., 2011. Catechol polymers for pH-responsive, targeted drug delivery to cancer cells. J. Am. Chem. Soc. 133, 11850-11853.
33. Tian, Q., Zhang, C.N., Wang, X.H., Wang, W., Huang, W., Cha, R.T., Wang, C.H., Yuan, Z., Liu, M., Wan, H.Y., Tang, H., 2010. Glycyrrhetinic acid-modified chitosan/poly (ethylene glycol) nanoparticles for liver-targeted delivery. Biomaterials 31, 4748-4756.
34. Todorova, R., 2011. Comparative analysis of the methods of drug and protein delivery for the treatment of cancer, genetic diseases and diagnostics. Drug Deliv. 18, 586-598.
35. Uppal, J.K., Varshney, R., Hazari, P.P., Chuttani, K., Kaushik, N.K., Mishra, A.K., 2011. Biological evaluation of avidin-based tumor pretargeting with DOTA-Triazole-Biotin constructed via versatile Cu(I) catalyzed click chemistry. J. Drug Target. 19, 418-426.
36. Urbanska, K., Lanitis, E., Poussin, M., Lynn, R.C., Gavin, B.P., Kelderman, S., Yu, J., Scholler, N., Powell Jr., D.J., 2012. A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptor. Cancer Res. 72, 1844-1852.
37. Wadhwa, M.S., Rice, K.G., 1995. Receptor mediated glycotargeting. J. Drug Target. 3, 111-127.
38. Wang, X.H., Tian, Q., Wang, W., Zhang, C.N., Wang, P., Yuan, Z., 2012a. In vitro evaluation of polymeric micelles based on hydrophobically-modified sulfated chitosan as a carrier of doxorubicin. J. Mater. Sci. Mater. Med. 23, 1663-1674.
39. Wang, Z., Yu, Y., Dai, W., Lu, J., Cui, J., Wu, H., Yuan, L., Zhang, H., Wang, X., Wang, J., Zhang, X., Zhang, Q., 2012b. The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer. Biomaterials 33, 8451-8460.
40. Watanabe, T., Umehara, T., Yasui, F., Nakagawa, S., Yano, J., Ohgi, T., Sonoke, S., Satoh, K., Inoue, K., Yoshiba, M., Kohara, M., 2007. Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome. J. Hepatol. 47, 744-750. (Pubitemid 350051113)
41. Xiong, X.Y., Gong, Y.C., Li, Z.L., Li, Y.P., Guo, L., 2011. Active targeting behaviors of biotinylated pluronic/poly(lactic acid) nanoparticles in vitro through three-step biotin-avidin interaction. J. Biomater. Sci. Polym. Ed. 22, 1607-1619.
42. Xu, H., Regino, C.A., Koyama, Y., Hama, Y., Gunn, A.J., Bernardo, M., Kobayashi, H., Choyke, P.L., Brechbiel, M.W., 2007. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Bioconjug. Chem. 18, 1474-1482. (Pubitemid 47464054)
43. Yang, K.W., Li, X.R., Yang, Z.L., Li, P.Z., Wang, F., Liu, Y., 2009a. Novel polyion complex micelles for liver-targeted delivery of diammonium glycyrrhizinate: in vitro and in vivo characterization. J. Biomed. Mater. Res. A 88, 140-148.
44. Yang, W., Cheng, Y., Xu, T., Wang, X., Wen, L.P., 2009b. Targeting cancer cells with biotinedendrimer conjugates. Eur. J. Med. Chem. 44, 862-868.
45. Yao, Q., Hou, S.X., Zhang, X., Zhao, G., Gou, X.J., You, J.Z., 2007. Preparation and characterization of biotinylated chitosan nanoparticles. Acta Pharmacol. Sin. 42, 557-561.
46. Yao, Q., Gan, L., Hou, S., Guo, X., Yan, J., Song, Q., Gou, X., 2012. Development and biodistribution of trans-resveratrol loaded chitosan nanoparticles with free amino groups. Lat. Am. J. Pharm. 31, 1038-1042.
47. Yao, Z., Zhang, M., Sakahara, H., Saga, T., Arano, Y., Konishi, J., 1998. Avidin targeting of intraperitoneal tumor xenografts. J. Natl. Cancer Inst. 90, 25-29. (Pubitemid 28078077)
48. Yao, Z., Zhang, M., Sakahara, H., Nakamoto, Y., Higashi, T., Zhao, S., Sato, N., Arano, Y., Konishi, J., 1999. The relationship of glycosylation and isoelectric point with tumor accumulation of avidin. J. Nucl. Med. 40, 479-483. (Pubitemid 29120124)